| # | Drug | Count |
|---|---|---|
| 0 | RITONAVIR | 39 |
| 1 | DARUNAVIR | 33 |
| 2 | LAMIVUDINE AND ZIDOVUDINE | 32 |
| 3 | PAROXETINE HYDROCHLORIDE | 27 |
| 4 | ERGOCALCIFEROL | 26 |
| 5 | LAMIVUDINE | 26 |
| 6 | LAMIVUDINE ORAL | 26 |
| 7 | CITALOPRAM | 25 |
| 8 | FLUOXETINE HYDROCHLORIDE | 25 |
| 9 | RITONAVIR 100 MG | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PIMOZIDE | 23 | 0.0477 |
| 1 | NAPROXEN SODIUM 220 MG | 2 | 0.0126 |
| 2 | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, CYANOCOBALAMIN, ZINC GLYCINATE, AND INTRINSIC FACTOR | 1 | 0.0102 |
| 3 | ABACAVIR AND LAMIVUDINE | 2 | 0.0100 |
| 4 | CABOTEGRAVIR SODIUM | 10 | 0.0062 |
| 5 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 2 | 0.0046 |
| 6 | LAMIVUDINE AND ZIDOVUDINE | 32 | 0.0042 |
| 7 | DICLOXACILLIN SODIUM | 3 | 0.0033 |
| 8 | MEBENDAZOLE | 2 | 0.0025 |
| 9 | NEVIRAPINE | 21 | 0.0023 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 47 | 0.0011 |
| 1 | Typical Antipsychotic [EPC] | 24 | 0.0010 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 21 | 0.0009 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 47 | 0.0008 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 38 | 0.0008 |
| 5 | Provitamin D2 Compound [EPC] | 22 | 0.0007 |
| 6 | Anthelmintic [EPC] | 2 | 0.0007 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 54 | 0.0005 |
| 8 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 9 | Bismuth [EPC] | 2 | 0.0004 |